Read More Pharma Industry News Eli Lilly acquires Organovo’s FXR program to advance IBD drug development In a significant industry development, Eli Lilly and Company has acquired Organovo Holdings, Inc.’s FXR program, including its… byPallavi MadhirajuFebruary 25, 2025